Both in Biotechnology
BioCryst Pharmaceuticals vs ADMA Biologics
Over the past year BCRX returned +24.9% and ADMA returned −27.7%; their daily moves had a correlation of 0.21.
BCRX +24.9% ADMA −27.7%Growth of $1, one year, split-adjusted
| Metric | BCRX | ADMA |
|---|---|---|
| Price | $8.57 | $11.11 |
| Market cap | $2.19B | $2.49B |
| Today | +3.94% | +0.45% |
| 1 month | +5.8% | +9.9% |
| 6 months | −5.1% | +8.4% |
| Year to date | +9.9% | −39.1% |
| 1 year | +17.1% | −28.2% |
| Revenue growth (YoY) | +33.6% | +2.0% |
| Gross margin | 98.2% | 69.4% |
| Net margin | 35.9% | 30.4% |
| P/E (TTM) | — | 14.7× |
| Price / sales | 2.3× | 4.9× |
| Net cash | -$471.6M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | 44.9% | 38.5% |
| Short % of float | 10.9% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).